Calcium Homeostasis Machinery in the Human Uterus—A Potential Therapeutic Target in Endometrial Cancer
International Journal of Molecular Sciences · 22.10.2025 · 26 (21) · 10253
DOI: 10.3390/ijms262110253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.10.2025. Verfasst von Piotr K Zakrzewski. Beteiligte Einrichtung: Department of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Homeostasis, Calcium, Uterus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometrial cancer is one of the most common malignancies of the female reproductive system, with incidence rising globally due to population ageing and life-style-related risk factors. Calcium (Ca2+) is a ubiquitous second messenger regulating diverse physiological processes, and its dysregulation has been increasingly implicated in carcinogenesis, including endometrial. Altered expression and function of Ca2+ channels, pumps, exchangers, and binding proteins disrupt the finely tuned balance of Ca2+ influx, efflux, and intracellular storage, leading to aberrant signalling that promotes tumour proliferation, migration, survival, and metastasis. This review summarises current knowledge on the molecular “Ca2+ toolkit” in the human uterus, highlighting the role of voltage-gated calcium channels (VGCCs), transient receptor potential (TRP) channels, store-operated calcium entry (SOCE) components, Na+/Ca2+ exchangers, purinergic receptors, P-type ATPases (SERCA, SPCA, PMCA), ryanodine (RyR) and inositol 1,4,5-trisphosphate (IP3R) receptors, and mitochondrial Ca2+ uniporter (MCU) complexes in endometrial cancer progression. Multiple Ca2+-handling proteins, including CACNA1D, CACNA2D1, TRPV4, TRPV1, TRPM4, MCU, and RyR1, exhibit cancer-associated overexpression or functional changes, correlating with poor prognosis and aggressive disease features. Emerging evidence supports the therapeutic potential of targeting Ca2+ homeostasis using small-molecule inhibitors, ion channel modulators or gene-silencing strategies. These interventions may restore Ca2+ balance, induce apoptosis or autophagy, and suppress metastatic behaviour. While no clinical trials have yet explicitly focused on Ca2+ modulation in endometrial cancer, the diversity of dysregulated Ca2+ pathways offers a rich landscape for novel therapeutic strategies. Targeting key components of the Ca2+ signalling network holds promise for improving outcomes in endometrial cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, 92-215 Lodz, Poland.
ORCID-Profile: Piotr K Zakrzewski
Zitieren
APA
Zakrzewski, P. K. (2025). Calcium Homeostasis Machinery in the Human Uterus—A Potential Therapeutic Target in Endometrial Cancer. International Journal of Molecular Sciences, 26(21), 10253. https://doi.org/10.3390/ijms262110253
Vancouver
Zakrzewski PK. Calcium Homeostasis Machinery in the Human Uterus—A Potential Therapeutic Target in Endometrial Cancer. International Journal of Molecular Sciences. 2025;26(21):10253. doi:10.3390/ijms262110253
BibTeX
@article{Zakrzewski2025,
author = {Zakrzewski, Piotr K},
title = {Calcium Homeostasis Machinery in the Human Uterus—A Potential Therapeutic Target in Endometrial Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10253},
doi = {10.3390/ijms262110253}
}
EUVIMED